Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL)

被引:19
作者
Kondo, S
Kotani, T
Tamura, K
Aratake, Y
Uno, H
Tsubouchi, H
Inoue, S
Niho, Y
Ohtaki, S
机构
[1] MIYAZAKI MED COLL, DEPT LAB MED, MIYAZAKI 88916, JAPAN
[2] MIYAZAKI MED COLL, DIV BLOOD TRANSFUS, MIYAZAKI 88916, JAPAN
[3] MIYAZAKI MED COLL, CENT LAB CLIN INVEST, MIYAZAKI 88916, JAPAN
[4] MIYAZAKI PREFECTURAL HOSP, MIYAZAKI, JAPAN
[5] MIYAZAKI MED COLL, DEPT DERMATOL, MIYAZAKI 88916, JAPAN
[6] KYUSHU UNIV, FAC MED, DEPT INTERNAL MED 1, FUKUOKA 812, JAPAN
关键词
ATLL; CD26; HTLV-I;
D O I
10.1016/0145-2126(95)00159-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association of CD26/dipeptidyl peptidase IV (DPPIV) and human T lymphotropic virus type I (HTLV-I) was studied by two approaches. First, we examined the expression of CD26 in peripheral blood mononuclear cells (PBMC) from the patients with adult T cell leukemia/lymphoma (ATLL), an HTLV-I-related malignancy. The expression of CD26 on the surface of PBMC was decreased in all 20 patients with ATLL compared with those from normal individuals (P<0.01) and the expression of the CD26 gene transcript was not detectable in seven out of eight patients with ATLL. Then we compared the quantity of viral DNA in CD26-negative (CD26-) and CD26-positive (CD26+) cells obtained from 17 HTLV-I healthy carriers by using a polymerase chain reaction method. The CD26- cells had a higher copy number of viral DNA than CD26+ cells. These findings indicate that HTLV-I has in vivo tropism to CD26- cells, suggesting that some phenotypes of ATLL cells reflect the in vivo cellular tropism of HTLV-I. (C) 1996 Published by Elsevier Science Ltd.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 35 条
[1]  
BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073
[2]  
BRODER CC, 1994, SCIENCE, V264, P1156, DOI 10.1126/science.7909959
[3]   T-CELL ACTIVATION ANTIGEN, CD26, AS A COFACTOR FOR ENTRY OF HIV IN CD4+ CELLS [J].
CALLEBAUT, C ;
KRUST, B ;
JACOTOT, E ;
HOVANESSIAN, AG .
SCIENCE, 1993, 262 (5142) :2045-2050
[4]  
DANG NH, 1990, J IMMUNOL, V145, P3963
[5]  
ENSSLE KH, 1990, CLIN EXP IMMUNOL, V79, P409
[6]   TRIGGERING OF THE LETHAL HIT IN HUMAN CYTOTOXIC LYMPHOCYTES-T - A FUNCTIONAL-ROLE FOR A 103-KDA T-CELL-SPECIFIC ACTIVATION ANTIGEN [J].
FLEISCHER, B ;
SCHENDEL, DJ ;
VONSTELDERN, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (07) :741-746
[7]   CD26 - A SURFACE PROTEASE INVOLVED IN T-CELL ACTIVATION [J].
FLEISCHER, B .
IMMUNOLOGY TODAY, 1994, 15 (04) :180-184
[8]  
FOX DA, 1984, J IMMUNOL, V133, P1250
[9]   C-FOS PROMOTER TRANS-ACTIVATION BY THE TAX1 PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I [J].
FUJII, M ;
SASSONECORSI, P ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8526-8530
[10]  
HAFLER DA, 1986, J IMMUNOL, V137, P414